Literature DB >> 27783333

Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease.

Craig A Marshall1, Ivan A Borbon1,2, Robert P Erickson3.   

Abstract

Nicotinamide delivered in drinking water at about 2 g/kg/day significantly prolonged survival and showed a suggestive improvement on memory in the Npc1 nih / Npc1 nih mouse model of infantile NPC1 disease. It is likely that this role is due to its function as a histone deacetylase (HDAC) inhibitor although another HDAC inhibitor, valproic acid, was without effect. Nicotinamide could also work by preventing/reversing oxidative stress.

Entities:  

Keywords:  Histone deacetylase; Nicotinamide; Niemann-Pick C1 disease; Oxidative stress; Sirtuin; Valproic acid

Mesh:

Substances:

Year:  2016        PMID: 27783333     DOI: 10.1007/s13353-016-0367-0

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  23 in total

1.  Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's.

Authors:  Ivan A Borbon; Robert P Erickson
Journal:  J Appl Genet       Date:  2010-12-18       Impact factor: 3.240

2.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C.

Authors:  Eric C Bascuñan-Castillo; Robert P Erickson; Christy M Howison; Robert J Hunter; Randall H Heidenreich; Chad Hicks; Theodore P Trouard; Robert J Gillies
Journal:  J Appl Genet       Date:  2004       Impact factor: 3.240

4.  Oxidative stress in Niemann-Pick disease, type C.

Authors:  Rao Fu; Nicole M Yanjanin; Simona Bianconi; William J Pavan; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2010-07-27       Impact factor: 4.797

5.  δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.

Authors:  Miao Xu; Ke Liu; Manju Swaroop; Forbes D Porter; Rohini Sidhu; Sally Firnkes; Sally Finkes; Daniel S Ory; Juan J Marugan; Jingbo Xiao; Noel Southall; William J Pavan; Cristin Davidson; Steven U Walkley; Alan T Remaley; Ulrich Baxa; Wei Sun; John C McKew; Christopher P Austin; Wei Zheng
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.

Authors:  Benny Liu; Stephen D Turley; Dennis K Burns; Anna M Miller; Joyce J Repa; John M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

7.  The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential.

Authors:  Zhao Zhong Chong; Shi-Hua Lin; Kenneth Maiese
Journal:  J Cereb Blood Flow Metab       Date:  2004-07       Impact factor: 6.200

8.  Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Authors:  Kim N Green; Joan S Steffan; Hilda Martinez-Coria; Xuemin Sun; Steven S Schreiber; Leslie Michels Thompson; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

9.  Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor.

Authors:  Sun-Jung Kim; Bong-Hee Lee; Yong-Soon Lee; Kyung-Sun Kang
Journal:  Biochem Biophys Res Commun       Date:  2007-07-02       Impact factor: 3.575

Review 10.  Histone deacetylase inhibitors open new doors in cancer therapy.

Authors:  Fiona McLaughlin; Nicholas B La Thangue
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

View more
  3 in total

Review 1.  Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 2.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 3.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.